Review





Similar Products

93
MedChemExpress senicapoc
Senicapoc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/senicapoc/product/MedChemExpress
Average 93 stars, based on 1 article reviews
senicapoc - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Icagen Inc senicapoc
Senicapoc, supplied by Icagen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/senicapoc/product/Icagen Inc
Average 90 stars, based on 1 article reviews
senicapoc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Pfizer Inc senicapoc pf-05416266
Senicapoc Pf 05416266, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/senicapoc pf-05416266/product/Pfizer Inc
Average 90 stars, based on 1 article reviews
senicapoc pf-05416266 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Icagen Inc senicapoc ica17043
Senicapoc Ica17043, supplied by Icagen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/senicapoc ica17043/product/Icagen Inc
Average 90 stars, based on 1 article reviews
senicapoc ica17043 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Selleck Chemicals senicapoc
Senicapoc, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/senicapoc/product/Selleck Chemicals
Average 90 stars, based on 1 article reviews
senicapoc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Merck & Co senicapoc
Names, 2D structures and references of the compounds mentioned in the introduction.
Senicapoc, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/senicapoc/product/Merck & Co
Average 90 stars, based on 1 article reviews
senicapoc - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Names, 2D structures and references of the compounds mentioned in the introduction.

Journal: International Journal of Molecular Sciences

Article Title: IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration

doi: 10.3390/ijms242216285

Figure Lengend Snippet: Names, 2D structures and references of the compounds mentioned in the introduction.

Article Snippet: Clotrimazole, senicapoc and paxilline were purchased from Merck (Milan, Italy)and dissolved in DMSO to prepare stock solutions according to the information provided from the manufacturer.

Techniques:

IK blockers affect WM266−4 and Panc−1 viability regardless of IK channel expression. ( A ) Relative KCNN4 expression from RT-qPCR showing the difference in KCNN4 mRNA levels between WM266-4 and Panc-1 (N = 3). ( B ) Results from MTT viability assays after 72 h of exposure to 30 µM clotrimazole, 30 µM senicapoc or the corresponding amount of DMSO (N = 4 for all). Data are reported as absorbance (570 nm) ratio drug-/DMSO-treated cells (color code reported in the legend). ( C ) Exemplary pictures from experiments in ( B ): WM266-4 and Panc-1 cells treated for 72 h with 30 µM clotrimazole, 30 µM senicapoc or the corresponding amount of DMSO. Significance level is indicated by two asterisks ( p < 0.01).

Journal: International Journal of Molecular Sciences

Article Title: IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration

doi: 10.3390/ijms242216285

Figure Lengend Snippet: IK blockers affect WM266−4 and Panc−1 viability regardless of IK channel expression. ( A ) Relative KCNN4 expression from RT-qPCR showing the difference in KCNN4 mRNA levels between WM266-4 and Panc-1 (N = 3). ( B ) Results from MTT viability assays after 72 h of exposure to 30 µM clotrimazole, 30 µM senicapoc or the corresponding amount of DMSO (N = 4 for all). Data are reported as absorbance (570 nm) ratio drug-/DMSO-treated cells (color code reported in the legend). ( C ) Exemplary pictures from experiments in ( B ): WM266-4 and Panc-1 cells treated for 72 h with 30 µM clotrimazole, 30 µM senicapoc or the corresponding amount of DMSO. Significance level is indicated by two asterisks ( p < 0.01).

Article Snippet: Clotrimazole, senicapoc and paxilline were purchased from Merck (Milan, Italy)and dissolved in DMSO to prepare stock solutions according to the information provided from the manufacturer.

Techniques: Expressing, Quantitative RT-PCR

Clotrimazole and senicapoc decrease the migration of WM266-4 and Panc-1. ( A ) Migration rate from trans-well migration assays of cells exposed to 30 µM clotrimazole or 30 µM senicapoc with respect to DMSO-treated cells (N = 4 for all). Different cell lines and treatments are color coded as reported in the legend. ( B ) Relative increases of cell-covered areas at t = 24 h with respect to t = 0 from the same petri dish for WM266-4 (DMSO N = 9, clotrimazole N = 9, senicapoc N = 8) and Panc-1 (DMSO N = 6, clotrimazole N = 6, senicapoc N = 5). Data are significantly different from control for WM266-4, clotrimazole ( p = 0.0128), WM266-4, senicapoc ( p = 0.001), and Panc-1, senicapoc ( p = 0.0246). Significance level is indicated by an asterisk ( p < 0.05).

Journal: International Journal of Molecular Sciences

Article Title: IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration

doi: 10.3390/ijms242216285

Figure Lengend Snippet: Clotrimazole and senicapoc decrease the migration of WM266-4 and Panc-1. ( A ) Migration rate from trans-well migration assays of cells exposed to 30 µM clotrimazole or 30 µM senicapoc with respect to DMSO-treated cells (N = 4 for all). Different cell lines and treatments are color coded as reported in the legend. ( B ) Relative increases of cell-covered areas at t = 24 h with respect to t = 0 from the same petri dish for WM266-4 (DMSO N = 9, clotrimazole N = 9, senicapoc N = 8) and Panc-1 (DMSO N = 6, clotrimazole N = 6, senicapoc N = 5). Data are significantly different from control for WM266-4, clotrimazole ( p = 0.0128), WM266-4, senicapoc ( p = 0.001), and Panc-1, senicapoc ( p = 0.0246). Significance level is indicated by an asterisk ( p < 0.05).

Article Snippet: Clotrimazole, senicapoc and paxilline were purchased from Merck (Milan, Italy)and dissolved in DMSO to prepare stock solutions according to the information provided from the manufacturer.

Techniques: Migration

Ca 2+ −evoked whole-cell currents of WM266−4 cells. ( A ) Exemplary current traces of WM266-4 whole-cell currents when the patch pipette was filled with the Ca 2+ -free intracellular solution. ( B ) Distribution of current amplitudes in WM266-4 cells measured at 100 mV with 1 µM Ca 2+ in the pipette solution. ( C ) Exemplary WM266-4 current traces from recordings with 1 µM Ca 2+ in the intracellular solution; cells were perfused with standard bath solution (top) or with the same solution + 1 µM senicapoc (bottom). ( D ) Exemplary Panc-1 current traces from recordings with 1 µM Ca 2+ in the intracellular solution; cells were perfused with standard bath solution (top) or with the same solution + 1µM clotrimazole (bottom). ( E ) Average normalized IVs of WM266-4 cells before (blue circles) and after (green circles) application of 1 µM senicapoc (N = 4 cells). Currents are normalized to the value at 100 mV. ( F ) Average normalized IVs of WM266-4 cells before (blue circles) and after (red circles) application of 1 µM clotrimazole (N = 4). Currents are normalized to the value at 100 mV. ( G ) Background-subtracted currents (background was calculated from the mean of 4 cells measured in Ca 2+ -free conditions) in the presence/absence of senicapoc normalized to the currents measured in standard bath solution at the same voltage in the same cells (mean ± SE, N = 4). ( H ) Background-subtracted currents in the presence/absence of clotrimazole normalized for the currents measured in standard bath solution at the same voltage in the same cells (mean ± SE, N = 4). Significance level is indicated by two asterisks ( p < 0.01).

Journal: International Journal of Molecular Sciences

Article Title: IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration

doi: 10.3390/ijms242216285

Figure Lengend Snippet: Ca 2+ −evoked whole-cell currents of WM266−4 cells. ( A ) Exemplary current traces of WM266-4 whole-cell currents when the patch pipette was filled with the Ca 2+ -free intracellular solution. ( B ) Distribution of current amplitudes in WM266-4 cells measured at 100 mV with 1 µM Ca 2+ in the pipette solution. ( C ) Exemplary WM266-4 current traces from recordings with 1 µM Ca 2+ in the intracellular solution; cells were perfused with standard bath solution (top) or with the same solution + 1 µM senicapoc (bottom). ( D ) Exemplary Panc-1 current traces from recordings with 1 µM Ca 2+ in the intracellular solution; cells were perfused with standard bath solution (top) or with the same solution + 1µM clotrimazole (bottom). ( E ) Average normalized IVs of WM266-4 cells before (blue circles) and after (green circles) application of 1 µM senicapoc (N = 4 cells). Currents are normalized to the value at 100 mV. ( F ) Average normalized IVs of WM266-4 cells before (blue circles) and after (red circles) application of 1 µM clotrimazole (N = 4). Currents are normalized to the value at 100 mV. ( G ) Background-subtracted currents (background was calculated from the mean of 4 cells measured in Ca 2+ -free conditions) in the presence/absence of senicapoc normalized to the currents measured in standard bath solution at the same voltage in the same cells (mean ± SE, N = 4). ( H ) Background-subtracted currents in the presence/absence of clotrimazole normalized for the currents measured in standard bath solution at the same voltage in the same cells (mean ± SE, N = 4). Significance level is indicated by two asterisks ( p < 0.01).

Article Snippet: Clotrimazole, senicapoc and paxilline were purchased from Merck (Milan, Italy)and dissolved in DMSO to prepare stock solutions according to the information provided from the manufacturer.

Techniques: Transferring

Panc−1 cells lack functional IK channels. ( A ) Current traces measured from a typical Panc-1 cell with 1 µM Ca 2+ in the patch pipette in standard extracellular solution (top left), during perfusion with 1 µM senicapoc (top right), with 1 µM clotrimazole (bottom left) or 1 µM paxilline (bottom right). ( B ) Average normalized current voltage relationship in control conditions (turquoise symbols), in 1 µM senicapoc (green symbols, N = 7), 1 µM clotrimazole (red symbols, N = 7) and 1 µM paxilline (black symbols, N = 7) (currents are normalized to those measured in control conditions at 100 mV; error bars indicate SEM). ( C ) Average current density normalized to that measured in control conditions at 100 mV in the indicated conditions.

Journal: International Journal of Molecular Sciences

Article Title: IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration

doi: 10.3390/ijms242216285

Figure Lengend Snippet: Panc−1 cells lack functional IK channels. ( A ) Current traces measured from a typical Panc-1 cell with 1 µM Ca 2+ in the patch pipette in standard extracellular solution (top left), during perfusion with 1 µM senicapoc (top right), with 1 µM clotrimazole (bottom left) or 1 µM paxilline (bottom right). ( B ) Average normalized current voltage relationship in control conditions (turquoise symbols), in 1 µM senicapoc (green symbols, N = 7), 1 µM clotrimazole (red symbols, N = 7) and 1 µM paxilline (black symbols, N = 7) (currents are normalized to those measured in control conditions at 100 mV; error bars indicate SEM). ( C ) Average current density normalized to that measured in control conditions at 100 mV in the indicated conditions.

Article Snippet: Clotrimazole, senicapoc and paxilline were purchased from Merck (Milan, Italy)and dissolved in DMSO to prepare stock solutions according to the information provided from the manufacturer.

Techniques: Functional Assay, Transferring

Senicapoc and clotrimazole do not alter the intracellular Ca 2+ concentration. ( A ) [Ca 2+ ] i over time from 32 WM266-4 cells (color code in the legend). ( B ) Mean Δ[Ca 2+ ] i from ( A ) with respect to bath solution (color-coded as in ( A ), N = 32). ( C ) Mean [Ca 2+ ] i over time from 32 Panc-1 cells (color-coded as in ( A )). ( D ) mean Δ[Ca 2+ ] i from ( C ) with respect to bath solution (color-coded as in ( C ), N = 32).

Journal: International Journal of Molecular Sciences

Article Title: IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration

doi: 10.3390/ijms242216285

Figure Lengend Snippet: Senicapoc and clotrimazole do not alter the intracellular Ca 2+ concentration. ( A ) [Ca 2+ ] i over time from 32 WM266-4 cells (color code in the legend). ( B ) Mean Δ[Ca 2+ ] i from ( A ) with respect to bath solution (color-coded as in ( A ), N = 32). ( C ) Mean [Ca 2+ ] i over time from 32 Panc-1 cells (color-coded as in ( A )). ( D ) mean Δ[Ca 2+ ] i from ( C ) with respect to bath solution (color-coded as in ( C ), N = 32).

Article Snippet: Clotrimazole, senicapoc and paxilline were purchased from Merck (Milan, Italy)and dissolved in DMSO to prepare stock solutions according to the information provided from the manufacturer.

Techniques: Concentration Assay

Effect of IK blockers on F-actin organization. WM266-4 ( A ) and Panc-1 ( B ) cells incubated for 24 h in vehicle alone or with 30 µM clotrimazole, 30 µM senicapoc or the corresponding volume of DMSO, which have subsequently been labeled with phalloidin (red) and DAPI (blue) and processed for fluorescence microscopy (see ).

Journal: International Journal of Molecular Sciences

Article Title: IK Channel-Independent Effects of Clotrimazole and Senicapoc on Cancer Cells Viability and Migration

doi: 10.3390/ijms242216285

Figure Lengend Snippet: Effect of IK blockers on F-actin organization. WM266-4 ( A ) and Panc-1 ( B ) cells incubated for 24 h in vehicle alone or with 30 µM clotrimazole, 30 µM senicapoc or the corresponding volume of DMSO, which have subsequently been labeled with phalloidin (red) and DAPI (blue) and processed for fluorescence microscopy (see ).

Article Snippet: Clotrimazole, senicapoc and paxilline were purchased from Merck (Milan, Italy)and dissolved in DMSO to prepare stock solutions according to the information provided from the manufacturer.

Techniques: Incubation, Labeling, Fluorescence, Microscopy